INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 99 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $18,000 | -50.0% | 16,200 | +0.6% | 0.00% | – |
Q4 2021 | $36,000 | -34.5% | 16,100 | 0.0% | 0.00% | – |
Q3 2021 | $55,000 | +14.6% | 16,100 | 0.0% | 0.00% | – |
Q2 2021 | $48,000 | -86.5% | 16,100 | -85.4% | 0.00% | – |
Q1 2017 | $355,000 | +136.7% | 110,000 | -1.2% | 0.00% | – |
Q4 2016 | $150,000 | -14.3% | 111,300 | -0.8% | 0.00% | – |
Q3 2016 | $175,000 | +17.4% | 112,210 | 0.0% | 0.00% | – |
Q2 2016 | $149,000 | -59.2% | 112,210 | +62.1% | 0.00% | – |
Q1 2016 | $365,000 | -32.8% | 69,210 | 0.0% | 0.00% | – |
Q4 2015 | $543,000 | -19.0% | 69,210 | -12.7% | 0.00% | -100.0% |
Q3 2015 | $670,000 | -57.6% | 79,310 | -45.0% | 0.00% | 0.0% |
Q2 2015 | $1,580,000 | +42.3% | 144,330 | +81.8% | 0.00% | 0.0% |
Q1 2015 | $1,110,000 | -17.2% | 79,400 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $1,341,000 | +25.8% | 79,400 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $1,066,000 | +1.0% | 79,400 | -4.1% | 0.00% | 0.0% |
Q2 2014 | $1,055,000 | +7.2% | 82,800 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $984,000 | -18.9% | 82,800 | -5.8% | 0.00% | 0.0% |
Q4 2013 | $1,214,000 | -27.3% | 87,900 | -8.1% | 0.00% | -50.0% |
Q3 2013 | $1,669,000 | -7.3% | 95,662 | -13.6% | 0.00% | 0.0% |
Q2 2013 | $1,800,000 | – | 110,751 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,354,963 | $38,132,000 | 1.80% |
Orbimed Advisors | 4,520,800 | $73,201,000 | 1.55% |
QVT Financial LP | 1,326,610 | $21,480,000 | 1.44% |
BB BIOTECH AG | 1,089,828 | $17,646,000 | 1.27% |
Meditor Group Ltd | 250,000 | $4,048,000 | 0.55% |
Perimeter Capital Partners, LLC | 159,915 | $2,589,000 | 0.50% |
EMERALD MUTUAL FUND ADVISERS TRUST | 156,808 | $2,539,000 | 0.43% |
Broadfin Capital, LLC | 117,172 | $1,897,000 | 0.37% |
OXFORD ASSET MANAGEMENT LLP | 811,331 | $13,184,000 | 0.36% |
Baker Brothers Advisors | 1,016,433 | $16,458,000 | 0.33% |